|
|
Volumn 2008, Issue 3, 2008, Pages 237-252
|
|
What is new on thyroid cancer biomarkers
|
|
Author keywords
Biomarkers; FNAC; Molecular signals; Thyroid cancer; Tumorigenesis pathways
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
B RAF KINASE;
BIOLOGICAL MARKER;
CALCITONIN;
CYTOKERATIN 19;
GALECTIN 3;
HISTONE DEACETYLASE INHIBITOR;
MOLECULAR MARKER;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
PHOSPHOTRANSFERASE INHIBITOR;
PLASMINOGEN ACTIVATOR;
PROTEIN RET;
RAS PROTEIN;
RETINOID DERIVATIVE;
SCATTER FACTOR RECEPTOR;
TRANSCRIPTION FACTOR PAX8;
ASPIRATION BIOPSY;
CLINICAL PRACTICE;
CYTOLOGY;
DIAGNOSTIC ACCURACY;
DRUG SYNTHESIS;
FOLLOW UP;
HISTOPATHOLOGY;
HUMAN;
IMMUNOHISTOCHEMISTRY;
PROGNOSIS;
REVIEW;
THYROID CANCER;
THYROID FOLLICLE;
THYROID FOLLICULAR CARCINOMA;
THYROID MEDULLARY CARCINOMA;
THYROID NODULE;
THYROID PAPILLARY CARCINOMA;
VALIDATION PROCESS;
|
|
EID: 43349098673
PISSN: None
EISSN: 11772719
Source Type: Journal
DOI: 10.4137/bmi.s669 Document Type: Review |
|
Times cited : (38)
|
|
References (203)
|
